AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
The current AstraZeneca(AZN) stock price is $169.62, with a market capitalization of 263.46B. The stock trades at a price-to-earnings (P/E) ratio of 25.26 and offers a dividend yield of 1.86%.
AstraZeneca(AZN) stock opened on 2026-07-20 at $168.14. The price climbed to — and dipped to —.
The AstraZeneca(AZN)'s current trading volume is 0, compared to an average daily volume of 3.24M.
During the past year, AstraZeneca(AZN) stock moved between $137.23 at its lowest and $212.71 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $137.23 at its lowest and $212.71 at its peak.
AZN News
...
Cathie Wood's ARK Genomic Revolution ETF (ARKG 0.55%) focuses on companies in the genomics sector, especially in healthcare. Since the beginning of July, Wood h...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an...
Analyst ratings
80%
of 30 ratingsMore AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an...
Dizal announced that it has entered into a global exclusive license agreement with AstraZeneca (AZN) for Zegfrovy, an oral irreversible epidermal growth factor...
AstraZeneca will pay $600 million initially, and make additional payments of up to $900 million upon reaching goals. Paul Ellis / Agence France-Presse / Getty I...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.